Ligand validation:5WIM

35R: 1-cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea

35R is a Ligand Of Interest in 5WIM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WIM_35R_A_901	53%	6%	0.178	0.941	2.54	2.42	13	8	0	0	100%	1
5UT0_35R_A_903	67%	13%	0.124	0.933	2.63	1.4	9	6	1	0	100%	1
6D2I_35R_A_901	6%	8%	0.385	0.83	2.57	2.14	13	7	2	0	100%	1
4QMM_35R_A_401	74%	31%	0.106	0.936	1.58	1.18	8	3	1	0	100%	1
5N23_35R_A_401	41%	13%	0.172	0.887	2.73	1.27	11	4	0	0	100%	0.61
6CPG_35R_A_501	4%	3%	0.322	0.715	1.86	4.45	8	12	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.